SODA (severity of dyspepsia assessment): A new effective outcome measure for dyspepsia-related health

Journal of Clinical Epidemiology

Volumn 54, Issue 8, 2001, Pages 755-765

  Rabeneck, Linda ^a,b   Cook, Karon F ^a   Wristers, Kimberly ^a   Souchek, Julianne ^a   Menke, Terri ^a   Wray, Nelda P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dyspepsia; Health status; Outcome measure; Quality of life

Indexed keywords

OMEPRAZOLE; PLACEBO;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DYSPEPSIA; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; SYMPTOMATOLOGY; TREATMENT OUTCOME; VALIDATION PROCESS;

ADULT; AGED; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; PATIENT SATISFACTION; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 0034904813     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(00)00365-6     Document Type: Article

References (66)

1. Management of dyspepsia: Report of a working party
2. Definition and investigation of dyspepsia: Consensus of an international ad hoc working party
3. Definitions of dyspepsia
4. Functional dyspepsia: A classification with guidelines for diagnosis and management
5. Prevalence of symptoms of dyspepsia in the community
6. Cost of digestive diseases in the United States
7. Do young patients with dyspepsia need investigation?
8. Early detection of gastric cancer
9. The predictive value of history in dyspepsia
10. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: A randomized, controlled study
11. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer
12. Helicobacter pylori in peptic ulcer disease
13. Alternative management strategies for patients with suspected peptic ulcer disease
14. Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: A decision analysis
15. Diagnosing dyspepsia: Any controversies left?
16. A patient questionnaire to identify bowel disease
17. Dyspepsia and dyspepsia subgroups: A population-based study
18. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy
19. Responsiveness to change: An aspect of validity, not a separate dimension
20. Evaluation of a multidimensional measure of dyspepsia-related health for use in a randomized clinical trial
21. Interpretation of change scores in ordinal clinical scales and health status measures: The whole may not equal the sum of the parts
22. Planning a randomized clinical trial in dyspepsia: Do we have a valid outcome measure?
23. Understanding changes in health status. Is the floor phenomenon merely the last step of the staircase?
24. Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: Results from the IQOLA Project
25. Dyspepsia: How should we measure it?
26. The McGill Pain Questionnaire: Major properties and scoring methods
27. A clinical comparison of two pain scales: Correlation, remembering chronic pain, and a measure of compliance
28. Studies with pain rating scales
29. EMG biofeedback and tension headache: A controlled outcome study
30. The measurement of clinical pain intensity: A comparison of six methods
31. Can severity of symptoms be used as an outcome measure in trials of non-ulcer dyspepsia and Helicobacter pylori associated gastritis?
32. A Rasch model for partial credit scoring
33. A rating formulation of ordered response categories
34. Chi-square fit statistics
35. Ordered response category analysis: A best practice model
36. Symptoms in gastro-oesophageal reflux disease
37. An introduction to structural equation models
38. Alternative ways of assessing model fit
39. Psychometric considerations in evaluating health-related quality of life measures
40. Methods for assessing responsiveness: A critical review and recommendations
41. Measuring change over time: Assessing the usefulness of evaluative instruments
42. Relative responsiveness of condition-specific and generic health status measures in degenerative lumbar spinal stenosis
43. A systematic overview (meta-analysis) of outcome measures in Helicobacter pylori gastritis trials and functional dyspepsia
44. A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia
45. Drug treatment of functional dyspepsia: A systematic analysis of trial methodology with recommendations for design of future trials
46. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia
47. Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia
48. Validation of a self-administered questionnaire to elicit gastrointestinal symptoms
49. Development of a new dyspepsia impact scale: The Nepean dyspepsia index
50. Developing a condition-specific measure of health for patients with dyspepsia and ulcer-related symptoms
51. A validated dyspepsia symptom score
52. The Glasgow dyspepsia severity score - A tool for the global measurement of dyspepsia
53. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia
54. Patient satisfaction in dyspepsia is related to pain symptoms
55. Increased numbers of women, older individuals, and African Americans receive health care for dyspepsia in the U.S.